Pain, Acute
Conditions
Brief summary
comparing two local anaesthetic agents, Bupivacaine 0.5% versus Oxybuprocaine used topically to provide surface anaesthesia before IVI procedures.
Detailed description
In preparation zone, we will cannulate the patients, connect them to the pulse oximetry and we will start providing appropriate surface anaesthesia for an adequate period of time before the patient administration of the injection, by applying the anaesthetic agents, 3 times with 5 minutes interval, for 15 minutes and then waitng the injection All patients are informed that they are going to receive topical anaesthetic agent before the IVI. pain is monitored during the injection by using the 11 points verbal numerical pain scaling as zero is for no pain and 10 is for severe unbearable pain.
Interventions
DRUGbupivacaine 0.5% and oxubuprocaine
using each drug as surface anesthesia before intravitreal injections
Sponsors
Research Institute of Ophthalmology, Egypt
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)
Intervention model description
double blinded randomized syudy
Eligibility
Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* All patients between 30 to 70 years
Exclusion criteria
* uncooperative patients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| verbal pain numerical scaling | 10 minutes | 11 point scale from 0-10 zero measns No pain 10 means severe unbearable pain |
Countries
Egypt
Outcome results
None listed